Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Next-Generation Sequencing for the Assessment of Measurable Residual Disease | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nerve Graft with Radical Prostatectomy | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Remote Electrical Neuromodulation (REN) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Negative Pressure Wound Therapy in the Outpatient Setting | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nedosiran (Rivfloza) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Necitumumab (Portrazza) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Natalizumab (Tysabri), Natalizumab-sztn (Tyruko) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Myocardial Sympathetic Innervation Imaging for Individuals with Heart Failure | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | RimabotulinumtoxinB (Myobloc) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Multiple Sclerosis Products:(Ocrelizumab [Ocrevus], Ocrelizumab and Hyaluronidase-ocsq [Ocrevus Zunovo], Ublituximab-xiiy [Briumvi]) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Multi-biomarker Testing for Rheumatoid Arthritis | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | MRI-guided Laser-induced Thermotherapy for Neurological Indications | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Tafasitamab-cxix (Monjuvi) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Molecular Markers in Fine Needle Aspirates of the Thyroid | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mogamulizumab-kpkc (Poteligeo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mitomycin (Zusduri) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mirikizumab-mrkz (Omvoh) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Microwave Ablation for Oncologic Tumors | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Microprocessor-Controlled Prostheses for the Lower Limb | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Vestronidase Alfa-vjbk(Mepsevii) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mepolizumab (Nucala) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mechanized Axial Spinal Distraction Therapy Devices | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mastectomy for Gynecomastia | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | FDA-Approved Indications | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Manipulation Under Anesthesia (MUA) of the Musculoskeletal System | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mammography | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Reduction Mammaplasty (Non-Cancerous) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Lymphatic Physiologic Microsurgery for Breast Cancer-Related Lymphedema | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Voretigene Neparvovec-rzyl (Luxturna) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Lutetium Lu 177 Vipivotide Tetraxetan (Pluvicto) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Luspatercept-aamt (Reblozyl) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Lurbinectedin (Zepzelca) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mosunetuzumab-axgb (Lunsumio, Lunsumio Velo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Low-Dose Radiotherapy for Non-Oncologic Indications | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Lovotibeglogene Autotemcel (Lyfgenia) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Toripalimab-tpzi (Loqtorzi) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Loncastuximab Tesirine-lpyl (Zynlonta) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pegzilarginase-nbln (Loargys) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Liposuction | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Liposuction and Lipectomy for Lipedema | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Lipectomy and Liposuction for Lymphedema | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Linvoseltamab-gcpt (Lynozyfic) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Light Emitting Diode (LED) Therapy | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Levoleucovorin (Fusilev), Levoleucovorin (Khapzory), Levoleucovorin | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Leuprolide Suspension (Lupron Depot, Leuprolide Acetate Depot)1-Month 3.75mg, 3-Month 11.25 mg) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Leuprolide Mesylate (Camcevi ETM; Camcevi Kit) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Leuprolide Acetate (Eligard, Vabrinty) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Leuprolide Acetate (Fensolvi) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Leuprolide Acetate Depot Suspension - [Lupron Depot (1 month) 7.5mg, Lupron Depot (3 month) 22.5mg, Lupron Depot (4-Month) 30 mg, Lupron Depot (6-Month) 45 mg]; Leuprolide Acetate Depot (3-month 22.5 mg): Lutrate Depot (3-month 22.5 mg) | Metadata changed |